Johan Schiettecatte,  Anne Van Opdenbosch,  Ellen Anckaert,  Jean De Schepper,  Kris Poppe,  Brigitte Velkeniers,  and Johan Smitz  ( Laboratory of Radioimmunology
and  Department of Endocrinology, University Hospital, Vrije Universiteit, Brussels, Belgium; * address correspondence to this author at: Laarbeeklaan 101, B-1090 Brussels, Belgium; fax 32-2-477-50-60, e-mail Johan.
Griffiths, Immunomedics' director, chemistry and radioimmunology
, presented a study revealing that tumor-bearing severe combined immunodeficient (SCID) mice given a monoclonal antibody labeled with the radioisotope Rhenium-188 showed an increased mean life expectancy of almost 50 percent.
We are highly grateful to the technical staff of the radioimmunology
unit of the Laboratoire Marcel Merieux (Lyon, France); to Christine Ferret, Patricia Herviaux, and Philippe Bonnet (Physiology Laboratory, Hopital Necker-Enfants Malades, Paris, France); and to Christine Dufour (Laboratoire de Biochimie, Hopital de Gonnesse, Gonnesse, France) for their excellent technical work.